Salarius Pharmaceuticals Changes Name to Decoy Therapeutics, Ticker Symbol to DCOY

miércoles, 7 de enero de 2026, 8:47 am ET1 min de lectura
SLRX--

Salarius Pharmaceuticals is changing its name to Decoy Therapeutics and its Nasdaq ticker symbol to DCOY, effective January 8, 2026. The name change reflects the company's focus on developing next-generation peptide conjugate therapeutics. Decoy's proprietary platform leverages AI-enabled computational infrastructure to accelerate candidate selection. The company's 2026 plan includes advancing its lead antiviral program into the clinic while expanding its pipeline and partnership opportunities.

Salarius Pharmaceuticals Changes Name to Decoy Therapeutics, Ticker Symbol to DCOY

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios